Q and A Adjuvant Atezolizumab Plus Bevacizumab Provides “Practice- Changing” Results in HCC
Adjuvant therapy with atezolizumab and bevacizumab improved recurrence-free survival in patients...
Read More
Ad Code: Imfinzi - Liver Cancer - AZ Imfinzi Himalaya- Display Banners HCP Wallboard Extension- JUL 202 - 56959
WB: Novel Antibody Provides Durable Responses in Bile Duct Cancer
An experimental antibody treatment targeting HER2 variants produced powerful results in patients with advanced bile duct cancers, according to findings published in The Lancet Oncology. For a phase 2b clinical trial, James...
Read MoreWB: Sarcopenia An “Urgent” Problem for Patients With HCC
Sarcopenia occurs often in patients with HCC, according to a large meta-analysis published in Oncology Letters. Researchers examined the prevalence of sarcopenia in patients with HCC in a literature review spanning March 2001 to...
Read More